Literature DB >> 7825120

Nitric oxide inhibits 3H-glutamate transport in synaptosomes.

S Pogun1, V Dawson, M J Kuhar.   

Abstract

3H-glutamate (GLU) uptake was measured in hippocampal synaptosomes from rat brain. Addition of sodium nitroprusside (SNP) (Sodium nitroferricyanide), a generator of nitric oxide (NO), produced a time-, temperature-, and dose-dependent inhibition of 3H-GLU uptake. The inhibition was due to changes in both Kd and Vmax of GLU uptake, and it was at least partially reversible upon washing. Addition of reduced hemoglobin (Hb), a substance that binds NO, prevented the SNP-induced depression of uptake. Potassium ferricyanide, a compound similar to SNP, did not cause a reduction in 3H-GLU uptake. Utilization of another generator of NO, S-nitroso-N-acetylpenicillamine (SNAP), produced similar results as did NO itself. Decreases in uptake were also observed in the striatum and cerebellum. Similar treatments did not consistently affect 3H-norepinephrine (NE) uptake, suggesting some selectivity in the NO effect. Thus, the observed inhibition of 3H-GLU uptake appears to be produced by NO, and it may represent a novel type of transynaptic retrograde regulation of transport. If found in vivo, inhibition of uptake activity could also be involved in the toxic effects of NO, the neurotoxicity of glutamate, and other potential neuronal changes associated with NO such as hippocampal long-term potentiation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7825120     DOI: 10.1002/syn.890180104

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  13 in total

Review 1.  Glutamate transporters in brain ischemia: to modulate or not?

Authors:  Weronika Krzyżanowska; Bartosz Pomierny; Magłorzata Filip; Joanna Pera
Journal:  Acta Pharmacol Sin       Date:  2014-03-31       Impact factor: 6.150

2.  Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant.

Authors:  L I Bruijn; M F Beal; M W Becher; J B Schulz; P C Wong; D L Price; D W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

Review 3.  Neuronal nitric oxide synthase and Hepatic Encephalopathy.

Authors:  V L Rao; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-09       Impact factor: 3.584

4.  Effect of nitric oxide donors on GABA uptake by rat brain synaptosomes.

Authors:  A Cupello; P Mainardi; M Robello; S Thellung
Journal:  Neurochem Res       Date:  1997-12       Impact factor: 3.996

5.  Simultaneous isolation of glial and neuronal fractions from rat brain homogenates: comparison of high-affinity L-glutamate transport properties.

Authors:  K K Daniels; T W Vickroy
Journal:  Neurochem Res       Date:  1998-01       Impact factor: 3.996

6.  Glutamate transporter EAAC-1-deficient mice develop dicarboxylic aminoaciduria and behavioral abnormalities but no neurodegeneration.

Authors:  P Peghini; J Janzen; W Stoffel
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

7.  Vicious cycle involving Na+ channels, glutamate release, and NMDA receptors mediates delayed neurodegeneration through nitric oxide formation.

Authors:  P J Strijbos; M J Leach; J Garthwaite
Journal:  J Neurosci       Date:  1996-08-15       Impact factor: 6.167

8.  Modulation of glutamine synthesis in cultured astrocytes by nitric oxide.

Authors:  M D Miñana; E Kosenko; G Marcaida; C Hermenegildo; C Montoliu; S Grisolía; V Felipo
Journal:  Cell Mol Neurobiol       Date:  1997-08       Impact factor: 5.046

9.  NMDA excitotoxicity and free radical generation in rat brain homogenates: application of a chemiluminescence assay.

Authors:  B Küçükkaya; G Haklar; A S Yalçin
Journal:  Neurochem Res       Date:  1996-12       Impact factor: 3.996

Review 10.  Methylene blue and its analogues as antidepressant compounds.

Authors:  Anzelle Delport; Brian H Harvey; Anél Petzer; Jacobus P Petzer
Journal:  Metab Brain Dis       Date:  2017-07-31       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.